Olmesartan Medoxomil and Rosuvastatin Tablets 20/10mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
MFDS item code 202003944 · Approved 2020.05.28
This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and dyslipidemia; suppression of atherosclerosis progression and the risk of cardiovascular disease
This medication is prescribed for patients who need to use both olmesartan medoxomil and rosuvastatin together. Olmesartan medoxomil is primarily used for the treatment of essential hypertension, helping to lower blood pressure and maintain cardiovascular health. Rosuvastatin is used for the treatment of hypercholesterolemia and various forms of dyslipidemia, serving as an adjunctive treatment when diet and exercise alone are insufficient. Additionally, rosuvastatin helps slow the progression of atherosclerosis and reduce the risk of cardiovascular diseases. In particular, it has been shown to reduce the risk of stroke, myocardial infarction, and revascularization procedures in high-risk patients with elevated high-sensitivity C-reactive protein and multiple risk factors for cardiovascular diseases. This medication improves cardiovascular health by managing both hypertension and hyperlipidemia simultaneously.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil/rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect occurs within 2 weeks after starting treatment and reaches its maximum effect at about 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose in patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended. ◆ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL-cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL-cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment Although no increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience of administration.
The safety and efficacy in children under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. It should not be administered to women who are allergic to this medicine, pregnant or breastfeeding, or to women of childbearing potential who are not using effective contraceptive methods. Avoid use in patients with severely impaired kidney function or liver function, those with biliary obstruction, or those with muscular diseases. Patients with genetic issues related to any of the components of this medication should not take it. Patients with very low blood pressure or reduced body sodium or blood volume may experience hypotension symptoms during the initial phase of treatment, and should be closely monitored. Patients with diminished kidney function or kidney transplant patients should regularly undergo blood tests to check kidney function and electrolyte status. Patients at risk for hyperkalemia should have their blood potassium levels monitored periodically, and caution is also warranted for patients with heart or cardiovascular disease. If symptoms such as muscle pain, weakness, or cramps occur during treatment, consult a doctor immediately. Liver function abnormalities may occur, so regular liver function tests before and during treatment are recommended. This medication may interact with other drugs, so inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or planning to become pregnant should avoid taking this medication, and should stop immediately if pregnancy is confirmed during treatment, using effective contraceptive methods. Breastfeeding women should also stop breastfeeding or discontinue this medication as it may affect the baby. The safety and efficacy in children under 18 years of age have not been established, and its use is not recommended. Elderly patients may require dose adjustments and monitoring due to increased drug concentration in the body. In case of overdose, symptoms such as hypotension and arrhythmias may occur, and immediate medical attention is necessary. This medication should be stored out of reach of children and must not be transferred to other containers.
Increased ALT, increased AST, elevated blood creatinine, reduced creatinine clearance, headache, dizziness, sensory impairment, neuromyopathy, drowsiness, gastroesophageal reflux disease, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal rigidity, atrial fibrillation, hypoglycemia, chest pain, tooth extraction, chest discomfort, peripheral edema, vertigo, abdominal pain, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, chronic malabsorption syndrome, rhabdomyolysis, hyperkalemia, acute kidney failure, hair loss, pruritus, urticaria, autoimmune hepatitis, dizziness (including positional vertigo), headache, palpitations, elevated blood pressure, low back pain, increased blood creatinine, diarrhea, pruritus, cough, nosebleed, upper respiratory infection, asthma, hypersensitivity reactions including angioedema, diabetes, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe myasthenia gravis, oculobulbar myasthenia gravis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, at a temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent degradation.
White or yellowish round film-coated tablets
30 tablets/box [30 tablets ((10 tablets/Alu-Alu) X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.